TCRT Earnings

Quarterly EPS
$-0.70
Q3 2024
$-0.46
Q4 2024
$-0.67
Q1 2025
$-0.63
Q2 2025
$-0.55
Q3 2025
$-0.43
Q4 2025
$-0.59
Q1 2026
$-0.41
Q2 2026
Latest RevenueN/A
Latest Net Income-952000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.410-952000+34.9%
Q1 2026-$0.590-1006000-100.0%+11.9%
Q4 2025-$0.433.0K-893000-25.0%+6.5%
Q3 2025-$0.550-1159000+21.4%
Q2 2025-$0.630-1051000-100.0%+11.3%
Q1 2025-$0.672.0K-1073000+100.0%+36.2%
Q4 2024-$0.464.0K-742000+300.0%+73.7%
Q3 2024-$0.700-1127000+86.8%
Q2 2024-$0.714.0K-1129000
Q1 2024-$1.051.0K-1682000
Q4 2023-$1.751.0K-7843000
Q3 2023-$5.300-8476000
Alaunos Therapeutics (TCRT) — Earnings